Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.
Also called NCT07227675
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 162 participants
- Sponsor
- Registry
-
NCT07227675
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT07227675. Allocation not applicable; no masking; primary purpose treatment. Start 2017-10-23 (actual); primary completion 2019-03-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
- Acronym
- COAPT CAS
- Condition
- Mitral Regurgitation
- Condition
- Mitral Valve Regurgitation
- Intervention (Device)
- MitraClip® NT System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct07227675- Content hash
c2330880e6a5c10ba37e3d43522b7d3c90fe98555d54dad8abce3b0902feb53f